Nimer Assy

4.6k total citations
92 papers, 3.2k citations indexed

About

Nimer Assy is a scholar working on Epidemiology, Hepatology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Nimer Assy has authored 92 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Epidemiology, 40 papers in Hepatology and 16 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Nimer Assy's work include Liver Disease Diagnosis and Treatment (41 papers), Liver Disease and Transplantation (16 papers) and Hepatitis C virus research (13 papers). Nimer Assy is often cited by papers focused on Liver Disease Diagnosis and Treatment (41 papers), Liver Disease and Transplantation (16 papers) and Hepatitis C virus research (13 papers). Nimer Assy collaborates with scholars based in Israel, Canada and United States. Nimer Assy's co-authors include William Nseir, Maria Grosovski, A. Djibre, Gattas Nasser, Raymond Farah, Alon Marmor, Kelly Kaita, David Mymin, Gerald Minuk and Barry Rosser and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Radiology.

In The Last Decade

Nimer Assy

87 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nimer Assy Israel 30 2.0k 1.1k 1.0k 570 443 92 3.2k
Wah‐Kheong Chan Malaysia 30 2.8k 1.4× 1.4k 1.3× 1.1k 1.0× 768 1.3× 299 0.7× 112 3.7k
Mario Masarone Italy 29 1.9k 1.0× 939 0.9× 660 0.6× 291 0.5× 316 0.7× 93 2.9k
Rachel M. Brown United Kingdom 21 1.7k 0.8× 599 0.6× 1.2k 1.2× 721 1.3× 337 0.8× 76 2.9k
Mark Muthiah Singapore 32 2.5k 1.2× 1.2k 1.2× 1.0k 1.0× 636 1.1× 403 0.9× 184 4.1k
Marcin Krawczyk Germany 33 1.8k 0.9× 898 0.8× 603 0.6× 1.1k 1.8× 387 0.9× 203 3.3k
Sanjaya K. Satapathy United States 31 2.5k 1.3× 1.7k 1.6× 674 0.7× 825 1.4× 271 0.6× 170 3.7k
Matilde Marcellini Italy 27 2.3k 1.2× 1.2k 1.1× 1.0k 1.0× 622 1.1× 307 0.7× 62 3.1k
Rodolphe Anty France 36 3.0k 1.5× 1.4k 1.3× 786 0.8× 1.1k 1.9× 865 2.0× 112 5.1k
Münevver Demir Germany 24 1.5k 0.8× 654 0.6× 619 0.6× 317 0.6× 383 0.9× 95 2.3k
Marialena Mouzaki United States 24 2.7k 1.4× 856 0.8× 1.2k 1.2× 852 1.5× 935 2.1× 98 4.0k

Countries citing papers authored by Nimer Assy

Since Specialization
Citations

This map shows the geographic impact of Nimer Assy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nimer Assy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nimer Assy more than expected).

Fields of papers citing papers by Nimer Assy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nimer Assy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nimer Assy. The network helps show where Nimer Assy may publish in the future.

Co-authorship network of co-authors of Nimer Assy

This figure shows the co-authorship network connecting the top 25 collaborators of Nimer Assy. A scholar is included among the top collaborators of Nimer Assy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nimer Assy. Nimer Assy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Basheer, Maamoun, et al.. (2023). Neurosarcoidosis: The Presentation, Diagnosis and Treatment Review of Two Cases. Life. 14(1). 69–69. 2 indexed citations
2.
Basheer, Maamoun, et al.. (2022). Regen-COV-2 Antibody Cocktail Mediated Clearance of SARS-COV-2 in an Immunocompromised Patient.. PubMed. 24(11). 695–696.
3.
Khoury, Tawfik, et al.. (2019). Predicting common bile duct stones by non-invasive parameters. Hepatobiliary & pancreatic diseases international. 19(3). 266–270. 10 indexed citations
4.
Zelber‐Sagi, Shira, Matthew Lee Smith, Samuel D. Towne, et al.. (2017). Role of illness perception and self-efficacy in lifestyle modification among non-alcoholic fatty liver disease patients. World Journal of Gastroenterology. 23(10). 1881–1881. 52 indexed citations
5.
Gane, Edward, Henry Lik‐Yuen Chan, G Choudhuri, et al.. (2010). 7 TREATMENT OF DECOMPENSATED HBV-CIRRHOSIS: RESULTS FROM 2-YEARS RANDOMIZED TRIAL WITH TELBIVUDINE OR LAMIVUDINE. Journal of Hepatology. 52. S4–S4. 13 indexed citations
6.
7.
Assy, Nimer. (2009). Approach to Solid Liver Masses in the Cirrhotic Patient. Gastroenterology Research. 2(5). 259–267. 2 indexed citations
8.
Assy, Nimer, Faris Nassar, Gattas Nasser, & Maria Grosovski. (2009). Olive oil consumption and non-alcoholic fatty liver disease. World Journal of Gastroenterology. 15(15). 1809–1809. 136 indexed citations
9.
Assy, Nimer, et al.. (2007). The Beneficial Effect of N-Acetylcysteine and Ciprofloxacin Therapy on the Outcome of Ischemic Fulminant Hepatic Failure. Digestive Diseases and Sciences. 52(12). 3507–3510. 5 indexed citations
10.
Assy, Nimer, et al.. (2007). Are Chronic Hepatitis C Viral Infections More Benign in Patients With Hemophilia?. The American Journal of Gastroenterology. 102(8). 1672–1676. 16 indexed citations
11.
Assy, Nimer. (2006). Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease. World Journal of Gastroenterology. 12(27). 4369–4369. 45 indexed citations
12.
Miron, Dan, et al.. (2006). Plasmodium and Borrelia Co-infection. Journal of Travel Medicine. 11(2). 115–116. 7 indexed citations
13.
Assy, Nimer, et al.. (2006). The changes in renal function after a single dose of intravenous furosemide in patients with compensated liver cirrhosis. BMC Gastroenterology. 6(1). 39–39. 11 indexed citations
14.
Hussein, Osamah, et al.. (2006). LDL oxidation is associated with increased blood hemoglobin A1c levels in diabetic patients. Clinica Chimica Acta. 377(1-2). 114–118. 20 indexed citations
15.
Assy, Nimer, et al.. (2004). CASE REPORT: Severe Cholestatic Jaundice in the Elderly Induced by Low-Dose Amiodarone. Digestive Diseases and Sciences. 49(3). 450–452. 1 indexed citations
16.
17.
Assy, Nimer, et al.. (2000). Fatty Infiltration of Liver in Hyperlipidemic Patients. Digestive Diseases and Sciences. 45(10). 1929–1934. 294 indexed citations
18.
Assy, Nimer, et al.. (1999). A Pilot Study on The Hemodynamic Effect of Short-Term Ursodeoxycholic Acid Therapy in Patients With Stable Liver Cirrhosis. The American Journal of Gastroenterology. 94(10). 3000–3004. 11 indexed citations
19.
Assy, Nimer, Ze’ev Hochberg, R Enat, & Yaacov Baruch. (1998). Prognostic Value of Generation of Growth Hormone-Stimulated Insulin-Like Growth Factor-I (IGF-I) and Its Binding Protein-3 in Patients with Compensated and Decompensated Liver Cirrhosis. Digestive Diseases and Sciences. 43(6). 1317–1321. 21 indexed citations
20.
Baruch, Yaacov, et al.. (1998). Spontaneous pulsatility and pharmacokinectics of growth hormone in liver cirrhotic patients. Journal of Hepatology. 29(4). 559–564. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wah‐Kheong Chan Breakdown of academic impact, for papers by Mario Masarone Breakdown of academic impact, for papers by Rachel M. Brown Breakdown of academic impact, for papers by Mark Muthiah Breakdown of academic impact, for papers by Marcin Krawczyk Breakdown of academic impact, for papers by Sanjaya K. Satapathy Breakdown of academic impact, for papers by Matilde Marcellini Breakdown of academic impact, for papers by Rodolphe Anty Breakdown of academic impact, for papers by Münevver Demir Breakdown of academic impact, for papers by Marialena Mouzaki
Rankless by CCL
2026